 Quinapril new second-generation ACE inhibitor Quinapril new non-sulfhydryl angiotensin-converting enzyme ACE inhibitor drug hepatic hydrolysis major active diacid metabolite quinaprilat minor inactive metabolites weight basis quinaprilat times potent ACE inhibitor quinapril percent oral dose quinapril contrast captopril absorption quinapril food Peak serum concentrations quinapril quinaprilat hours percent dose urine quinaprilat elimination half-life quinaprilat hours hours patients renal dysfunction Quinapril dose reduction patients creatinine clearance mL/sec elderly elimination quinaprilat correlates renal function patients cirrhosis hydrolysis quinapril impaired plasma quinaprilat concentrations two-fold increase quinapril half-life Quinaprilat strong binding capacity ACE once-daily dosing recommended starting dose quinapril mg/d nature incidence adverse reactions quinapril similar enalapril captopril Quinapril antihypertensive efficacy equal captopril enalapril small number patients congestive heart failure CHF quinapril Preliminary data indicate quinapril effective therapeutic alternative available ACE inhibitors treatment CHF